» Articles » PMID: 32756532

Exosomes Mediated Transfer of Circ_UBE2D2 Enhances the Resistance of Breast Cancer to Tamoxifen by Binding to MiR-200a-3p

Overview
Journal Med Sci Monit
Date 2020 Aug 7
PMID 32756532
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND Circular RNA UBE2D2 (circ_UBE2D2) has been found to be involved in the progression of breast cancer. Exosomes are critical mediators of intercellular communication, however, the function of exosomal circ_UBE2D2 in breast cancer remains vague. MATERIAL AND METHODS Cell viability was measured by Cell Counting Kit-8 assay. Western blot was used to detect the levels of estrogen receptor alpha (ERalpha), E-cadherin, vimentin, CD9, and CD63. Migrated and invaded cells were examined using Transwell assay. Circ_UBE2D2 and microRNA (miR)-200a-3p levels were detected using quantitative real-time polymerase chain reaction. Exosomes were isolated by ultracentrifugation method. The interaction between circ_UBE2D2 and miR-200a-3p was confirmed by dual-luciferase reporter assay and RNA immunoprecipitation assay. Murine xenograft model was established to conduct in vivo experiments. RESULTS We found that circ_UBE2D2 was upregulated in breast cancer tamoxifen-resistant tissues and cell lines, and circ_UBE2D2 deletion mitigated tamoxifen resistance in breast cancer cells. Circ_UBE2D2 was also significantly loaded in exosomes isolated from resistant cells and could be transferred to parental cells. MiR-200a-3p was a target of circ_UBE2D2, and we demonstrated that exosomes mediated transfer of circ_UBE2D2 interacted with miR-200a-3p to enhance tamoxifen resistance of breast cancer cells by regulating cell viability, metastasis, and the level of ERalpha in vivo and in vitro. CONCLUSIONS Exosomes mediated transfer of circ_UBE2D2 reinforced tamoxifen resistance in breast cancer by binding to miR-200a-3p, providing new insights into the boost of the effectiveness of tamoxifen on breast cancer patients.

Citing Articles

Exosomal circRNAs: Deciphering the novel drug resistance roles in cancer therapy.

Li X, Liu H, Xing P, Li T, Fang Y, Chen S J Pharm Anal. 2025; 15(2):101067.

PMID: 39957900 PMC: 11830318. DOI: 10.1016/j.jpha.2024.101067.


Extracellular Vesicles as Mediators and Potential Targets in Combating Cancer Drug Resistance.

Zhang H, Wu B, Wang Y, Du H, Fang L Molecules. 2025; 30(3).

PMID: 39942602 PMC: 11819960. DOI: 10.3390/molecules30030498.


The role of circRNA in breast cancer drug resistance.

Yang S, Li D PeerJ. 2024; 12:e18733.

PMID: 39713143 PMC: 11662897. DOI: 10.7717/peerj.18733.


Development and validation of disulfidptosis-related genes signature for patients with glioma.

Wang J, Luo J, Yang S, Deng Y, Chen P, Tan Y Discov Oncol. 2024; 15(1):758.

PMID: 39692962 PMC: 11655816. DOI: 10.1007/s12672-024-01664-z.


Molecular Profiling of Endocrine Resistance in HR+/HER2-Metastatic Breast Cancer: Insights from Extracellular Vesicles-Derived DNA and ctDNA in Liquid Biopsies.

Martinez-Rodriguez A, Fuentes-Antras J, Lorca V, Lopez de Sa A, Perez-Segura P, Moreno F Int J Mol Sci. 2024; 25(23).

PMID: 39684756 PMC: 11641624. DOI: 10.3390/ijms252313045.


References
1.
Liu Y, Dong Y, Zhao L, Su L, Luo J . Circular RNA‑MTO1 suppresses breast cancer cell viability and reverses monastrol resistance through regulating the TRAF4/Eg5 axis. Int J Oncol. 2018; 53(4):1752-1762. DOI: 10.3892/ijo.2018.4485. View

2.
Lee H, Kim C, Kang H, Tak H, Ahn S, Yoon S . microRNA-200a-3p increases 5-fluorouracil resistance by regulating dual specificity phosphatase 6 expression. Exp Mol Med. 2017; 49(5):e327. PMC: 5454440. DOI: 10.1038/emm.2017.33. View

3.
Mills J, Rutkovsky A, Giordano A . Mechanisms of resistance in estrogen receptor positive breast cancer: overcoming resistance to tamoxifen/aromatase inhibitors. Curr Opin Pharmacol. 2018; 41:59-65. PMC: 6454890. DOI: 10.1016/j.coph.2018.04.009. View

4.
Ding M, Sun X, Zhong J, Zhang C, Tian Y, Ge J . Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL. J Cell Biochem. 2018; 119(12):9974-9985. DOI: 10.1002/jcb.27326. View

5.
Wang Y, Li J, Du C, Zhang L, Zhang Y, Zhang J . Upregulated Circular RNA circ-UBE2D2 Predicts Poor Prognosis and Promotes Breast Cancer Progression by Sponging miR-1236 and miR-1287. Transl Oncol. 2019; 12(10):1305-1313. PMC: 6657235. DOI: 10.1016/j.tranon.2019.05.016. View